PHARMACEUTICAL CARE WHEN USING STATINS: THE ROLE OF THE PHARMACIST IN ENSURING AN ADEQUATE LEVEL OF PHARMACEUTICAL ASSISTANCE
DOI:
https://doi.org/10.11603/2312-0967.2026.1.15940Keywords:
statins, atherosclerosis, Pharmaceutical care, role of the pharmacist, efficacy and safety of therapyAbstract
The aim of the work. To determine the role of the pharmacist in implementation of pharmaceutical care during the dispense statins from the pharmacy.
Materials and Methods. The methodological basis of the study consists of the principles of objectivity and consistency. The work uses a set of general scientific and special methods: theoretical, generalisation, data systematisation, comparison, methods of studying literary references, analysis, questionnaires, etc. A questionnaire was conducted among 48 pharmacy visitors who visited the pharmacy to purchase statins.
Results and Discussion. The survey results showed the majority of respondents (72.9%) are aware that statins group are dispensed with a doctor’s prescription, while 27.1% of respondents buy them without a doctor’s prescription. The main sources of information about the medicinal properties of the statins group for most consumers are the doctor (54.1%) and the pharmacist (37.5%). Most pharmacy visitors take their statin drugs before bedtime (62.4%), but 10.5% do not follow a clear regimen. 43.7% of visitors do not fully understand the duration of therapy or believe that taking statins can be stopped after cholesterol levels normalize.
Conclusions. When dispensing statins from a pharmacy, conducting proper pharmaceutical care by pharmacist will help increase the efficacy and safety of pharmacotherapy.
References
World Health Organization. Cardiovascular diseases (CVDs) [Internet]. Geneva: WHO; 2025 [cited 2026 Jan 02]. Available from: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)
Tsao CW, Aday AW, Almarzooq ZI, Anderson CA, Arora P, Avery CL, et al. Heart Disease and Stroke Statistics – 2023 Update: A Report From the American Heart Association. Circulation. 2023;147(8):e93–e621. DOI:10.1161/CIR.0000000000001123 DOI: https://doi.org/10.1161/CIR.0000000000001137
Björkegren JLM, Lusis AJ. Atherosclerosis: Recent developments. Cell. 2022;185(10):1630–1645. DOI:10.1016/j.cell.2022.04.004 DOI: https://doi.org/10.1016/j.cell.2022.04.004
Zupanets IA, Chernykh VP, editors. Symptomy ta syndromy v praktychnii farmatsii. Pryntsypy terapii: navch. posib. 2nd ed. Kharkiv: Zoloti storinky; 2021. 120 p.
Cherska M. Kombinovana lipidoznyzhuvalna terapiia [Internet]. Neurocardiologist; 2024 Jul 11 [cited 2026 Jan 03]. Available from: https://neurocardiologist.info/ua/blog/kombinirovannaya-lipidosnizhayushchaya-terapiya/
Chernyshov VA. Suchasna hipolipidemichna terapiia: mozhlyvosti novykh hipolipidemichnykh preparativ shchodo korektsii porushen lipidnoho obminu. Ohliad literatury. Ukr Ter Zh. 2024;(1):59–69. DOI:10.30978/U59TJ2024-1-59 DOI: https://doi.org/10.30978/U59TJ2024-1-59
Amerykanski nastanovy shchodo kontroliu vmistu kholesterynu v krovi. Zdorov’ia Ukrainy. Kardiolohiia [Internet]. 2019 [cited 2026 Jan 06];(4):9. Available from: https://health-ua.com/multimedia/userfiles/files/2019/Cardio_4_2019/Cardio_4_2019_str_9.pdf
Ministry of Health of Ukraine. Prohrama reimbursatsii "Dostupni liky" [Internet]. Kyiv: MOH Ukraine; [cited 2026 Jan 06]. Available from: https://moz.gov.ua/uk/dev-dostupni-liki
Compendium. Likarski preparaty Ukrainy: onlain-dovidnyk [Internet]. Kyiv: Morion; 2026 [cited 2026 Jan 06]. Available from: https://compendium.com.ua
Rx index – Dovidnyk ekvivalentnosti likarskykh zasobiv [Internet]. Pharmpedia; 2026 [cited 2026 Jan 06]. Available from: https://pharmpedia.org/
Zhou L, Wu B, Bian Y, et al. Hepatotoxicity associated with statins: a retrospective pharmacovigilance study based on the FAERS database. PLoS One. 2025;20(7):e0327500. DOI:10.1371/journal.pone.0327500. DOI: https://doi.org/10.1371/journal.pone.0327500
Alves RJ. Statin use and hypercholesterolemia: are the current guidelines’ recommendations being followed? Arq Bras Cardiol. 2021;116(4):742-743. DOI:10.36660/abc.20210089. DOI: https://doi.org/10.36660/abc.20210089
Steel N, Fleetcroft B, Hassan Y. Prescribing statins in general practice: who decides? Br J Gen Pract. 2017;67(659):246-247. DOI:10.3399/bjgp17X690953. DOI: https://doi.org/10.3399/bjgp17X690953
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 Pharmaceutical Review / Farmacevtičnij časopis
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The authors who publish their materials in this journal agree with the following terms:
- Authors reserve the right to authorship of their work and assign to the journal the right to first publish this work under the terms of the Creative Commons Attribution License, which allows other persons to freely distribute the published work with a mandatory reference to the authors of original work and the first publication of work in this journal
. - Authors have the right to make independent extra-exclusive work agreements in the form they are published by this journal (for example, posting work in an electronic repository of an institution or publishing as part of a monograph), provided that the link to the first publication of the work in this journal is maintained.
Journal policy allows and encourages publication of manuscripts on the Internet (for example, in institutions repositories or on personal websites), both before the publication of this manuscript and during its editorial review, as it contributes to productive scientific discussion and positively affects the efficiency and dynamics of the citation of the published work (see The Effect of Open Access).
